TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
Phase 2B, multicenter study evaluating the safety and efficacy of weekly TOCOSOL Paclitaxel
in taxane-naive patients receiving second line chemotherapy for metastatic or locally
advanced, unresectable transitional cell carcinoma of the urothelium